Proteomic data in meningiomas: Post-proteomic analysis can reveal novel pathophysiological pathways

Journal of Neuro-Oncology

Volumn 104, Issue 2, 2011, Pages 401-410

  Herrmann, A ^a   Ooi, J ^a   Launay, S ^a   Searcy, J L ^a   Deighton, R F ^a   McCulloch, J ^a   Whittle, I R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Functional network; Meningioma; Pathophysiology; Proteomics

Indexed keywords

APOLIPOPROTEIN A1; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; VOLTAGE DEPENDENT ANION CHANNEL 2;

CANCER GRADING; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENINGIOMA; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SYSTEMATIC REVIEW; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN NEOPLASMS; HUMANS; MENINGIOMA; PROTEOMICS;

EID: 80052673823     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0526-9     Document Type: Review

References (27)

1. A Dhamoon E Kohn N Azad 2007 The ongoing evolution of proteomics in malignancy Drug Discov Today 12 17/18 700 708 17826682 10.1016/j.drudis.2007.07. 015 1:CAS:528:DC%2BD2sXhtVWhsrvN (Pubitemid 47362784)
2. J Micallef A Gajadhar J Wiley L DeSouza K Siu A Guha 2008 Proteomics: present and future implications in neuro-oncology Neurosurgery 62 3 539 555 18425004 10.1227/01.neu.0000317302.85837.61
3. C Mawrin A Perry 2010 Pathological classification and molecular genetics of meningiomas J Neurooncol 99 3 379 391 20809251 10.1007/s11060-010-0342-2 1:CAS:528:DC%2BC3cXht1Sru77L
4. Perry A, Louis D, Scheithauer B, Budka H, Von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon, pp 164-172
5. S Hanft P Canoll J Bruce 2010 A review of malignant meningiomas: diagnosis, characteristics, and treatment J Neurooncol 99 3 433 443 20730473 10.1007/s11060-010-0348-9 1:CAS:528:DC%2BC3cXht1Sru7%2FM
6. I Whittle C Smith P Navoo D Collie 2004 Meningiomas Lancet 363 1535 1543 15135603 10.1016/S0140-6736(04)16153-9 (Pubitemid 38596834)
7. M Sughrue A Kane G Shangari M Rutkowski M McDermott M Berger A Parsa 2010 The relevance of Simpson grade I and II resection in modern neurosurgical treatment of World Health Organization grade I meningiomas J Neurosurg 113 5 1029 1035 20380529 10.3171/2010.3.JNS091971
8. I Whittle D Short R Deighton L Kerr C Smith J Mcculloch 2006 Proteomic analysis of gliomas Br J Neurosurg 21 6 576 582 10.1080/02688690701721691 (Pubitemid 350249199)
9. R Deighton R McGregor J Kemp J McCulloch I Whittle 2010 Glioma pathophysiology: insights emerging from proteomics Brain Pathol 1015-6305 1 13
10. Ingenuity systems citing guidelines. Last updated 2009. Available from http://www.ingenuity.com
11. R Deighton L Kerr D Short M Allerhand I Whittle J McCulloch 2010 Network generation enhances interpretation of proteomic data from induced apoptosis Proteomics 10 1 9 10.1002/pmic.200900112
12. R Deighton D Short R McGregor A Gow I Whittle J McCulloch 2009 The utility of functional interaction and cluster analysis in CNS proteomics J Neurosci Methods 180 2 321 329 19464520 10.1016/j.jneumeth.2009.03.013 1:CAS:528:DC%2BD1MXmtlekurY%3D
13. H Okamoto J Li A Vortmeyet H Jaffe Y Lee S Glasker T Sohn W Zeng B Ikejiri M Proescholdt C Mayer R Weil E Oldfield Z Zhuang 2006 Comparative proteomic profiles of meningioma subtypes Cancer Res 66 20 10199 10204 17047085 10.1158/0008-5472.CAN-06-0955 1:CAS:528:DC%2BD28XhtVyiurzM (Pubitemid 44672075)
14. N Agar J Malcom V Mohan H Yang M Johnson A Tannenbaum J Agar P Black 2010 Imaging of meningioma progression by MALDI-TOF MS Anal Chem 82 7 2621 2625 20196536 10.1021/ac100113w 1:CAS:528:DC%2BC3cXis1Cns7g%3D
15. A Bouamrani C Ramus E Gay L Pelletier M Cubizolles S Brugiere D Wion F Berger J Issartel 2010 Increased phosphorylation of vimentin in noninfiltrative meningiomas PLoS ONE 5 2 e9238 20169076 10.1371/journal.pone.0009238
16. Y Kim M Klotz A Tholey W Henn K Schafer W Feiden 2009 Comparative proteome analyses of meningiomas of different grades in the identification of progression associated proteins Acta Neuropathol 118 433 467 10.1007/s00401-009-0573-5 1:CAS:528:DC%2BD1MXpt1Clsg%3D%3D Abstract
17. O Saydam O Senol T Schaaij-Visser T Pham S Piersma A Stemmer-Rachamimov T Wurdinger S Peerdeman C Jimenez 2010 Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas J Proteome Res 9 485 494 19877719 10.1021/pr900834h 1:CAS:528:DC%2BD1MXhsVeis7nP
18. Scholz M (2006) Proteomics-based identification of differentially expressed proteins in human meningiomas. German medical science (Meeting Abstract)
19. C Wibom L Moren M Aarhus P Knappskof M Lund-Johansen H Antti A Bergenheim 2009 Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtypes J Neurooncol 94 321 331 19350207 10.1007/s11060-009-9865-9 1:CAS:528:DC%2BD1MXhtVegsLrP
20. T Vogel Z Zhuang J Li H Okamoto M Furata Y Lee W Zeng E Oldfield A Vortmeyer R Weil 2005 Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme Clin Cancer Res 11 10 3624 3632 15897557 10.1158/1078-0432.CCR-04-2115 1:CAS:528:DC%2BD2MXktFyrsLk%3D (Pubitemid 40685577)
21. S Niclou F Fack U Rajcevic 2010 Glioma proteomics: status and perspectives J Proteomics 73 10 1823 1838 20332038 10.1016/j.jprot.2010.03.007 1:CAS:528:DC%2BC3cXhtFGjtr7F
22. J Willis C Smith J Ironside S Erridge I Whittle 2005 The accuracy of meningioma grading: a 10 year audit Neuropathol Appl Neurobiol 31 141 149 15771707 10.1111/j.1365-2990.2004.00621.x 1:STN:280:DC%2BD2M7ktVGqtw%3D%3D (Pubitemid 40444915)
23. J Pastorino J Hoek 2008 Regulation of hexokinase binding to VDAC J Bioenerg Biomembr 40 171 182 18683036 10.1007/s10863-008-9148-8 1:CAS:528:DC%2BD1cXhtFCrsr%2FF
24. J Taylor F Borthwick C Bartholomew A Graham 2010 Overexpression of stroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI Cardiovasc Res 86 526 534 20083572 10.1093/cvr/cvq015 1:CAS:528:DC%2BC3cXmtFKqtr0%3D
25. J Montero A Morales L Llacuna J Lluis, et al. 2008 Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma Cancer Res 68 5246 5256 18593925 10.1158/0008-5472.CAN-07-6161 1:CAS:528:DC%2BD1cXnvFyjsLo%3D
26. P Chong H Lee J Zhou S Liu, et al. 2010 Reduced plasma APOA1 level is associated with gastric tumour growth in MKN45 mouse xenograft model J Proteomics 73 1632 1640 20399916 10.1016/j.jprot.2010.04.005 1:CAS:528:DC%2BC3cXntlagtL4%3D
27. D Mogilenko E Dizhe V Shavva I Lapikov, et al. 2009 Role of the nuclear receptors HNF4α, PPARα, and LXRs in the TNFα-mediated inhibition of human apolipoprotein A-1 gene expression in HepG2 cells Biochemistry 48 11950 11960 19883121 10.1021/bi9015742 1:CAS:528: DC%2BD1MXhsVWmurnE